Research Highlights from the San Antonio Breast Cancer Symposium 2018
The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90...
The 41st San Antonio Breast Cancer Symposium, held Dec. 4-8, drew more than 7,500 attendees from more than 90...
To kick off the new year, the editors of the 10 AACR journals highlighted two phase I clinical trials,...
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
This week’s excitement surrounding the groundbreaking U.S. Food and Drug Administration (FDA) approval of the CAR T–cell therapy tisagenlecleucel...
By Nicholas Warren, PhD On Thursday, the U.S. Food and Drug Administration (FDA) Center for Tobacco Products (CTP) announced...
Grab a cold drink and escape the midsummer heat with July’s rendition of Editors’ Picks. This month, the editors...
Ten years ago, then-President of the AACR, Tyler Jacks, PhD, FAACR, conceived the idea for a “comprehensive, high-impact journal that would present new...
In the United States, nearly 24,000 people are estimated to receive a brain or nervous system cancer diagnosis in 2020....
The cover of the inaugural issue of Blood Cancer Discovery, launched in July 2020, does not feature stained tissue...
The new year has already ushered in some changes, but one thing stays the same. Each month, we’ll continue to feature the “must read” articles handpicked by the editors...
On May 4, the U.S. Food and Drug Administration (FDA) approved a combination of molecularly targeted therapeutics for the...
Adding the PI3-kinase inhibitor pictilisib to fulvestrant doubled progression-free survival for some women with advanced hormone-receptor positive breast cancer,...
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...
Immunotherapy has revolutionized cancer treatment over the past decade, providing potentially lifesaving therapies to many patients who otherwise would have limited options. Despite its success...
The staff of Cancer Research Catalyst was pleased to introduce a new feature this year: Editors' Picks, a monthly...
Another month brings another round of Editors’ Picks! As we picked our May flowers, the editors picked their favorite...
Editor’s note: When the San Antonio Breast Cancer Symposium (SABCS) kicks off next week, researchers will present the results...
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors...
Highlights of December 2023 AACR journals include clinical trial results, strategies to improve therapy, and a new cervical cancer...
Medical risks of obesity include high blood pressure, type 2 diabetes, and cardiovascular diseases. Additionally, obesity has been associated...
Back for the month of February is our regular staple, Editors’ Picks, which features the “must read” articles that...
2023 is upon us, but before we dive into the new year, let’s look back at the featured articles...
Although checkpoint inhibitors and other immunotherapies are remarkably effective for patients with some cancers, demonstrating durable antitumor activity and/or...
Last week, a flurry of U.S. Food and Drug Administration (FDA) oncology approvals concluded with the approval of the...
As we welcome in August, it’s time to look back at some of the top articles published in the nine AACR journals...
While the incidence of melanoma has been rising, the mortality rate has experienced a steep decline over the past few years. This is largely attributable...
The days are getting longer and warmer, and visions of beach trips, cookouts, and picnics occupy our minds. While this year’s summer will likely look different due to the ongoing COVID-19 pandemic, months...
Several options are available for the treatment of breast cancer, including local therapies such as surgery and radiation therapy,...
In the past year, the number of American teenagers using tobacco products has increased by nearly 40 percent, reversing...
The field of medical oncology is undergoing a remarkable transformation. Cancers that were once considered death sentences, such as...